Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib.

Source:http://linkedlifedata.com/resource/pubmed/id/19934289

Clin. Cancer Res. 2009 Dec 1 15 23 7153-60

Download in:

View as

General Info

PMID
19934289